Header image

Smoking & Vaping Cessation Update Day

Tracks
.
Sunday, November 8, 2026
1:00 PM - 4:00 PM
Carnac

Overview

Spotlighting the launch of cytisine in Australia for smoking cessation


Details

Don't miss this landmark APSAD SIG event marking the arrival of cytisine in Australia. With the first new smoking cessation treatment registered on the Australian Register of Therapeutic Goods in almost 20 years, this is a unique opportunity to hear from world-leading experts about the international evidence, Australian experience, and the future of smoking cessation treatment.


Speaker

Ryan Courtney
A/prof
Unsw

Acknowledgement of Country, welcome and introduction to the SVCP SIG Update Day

1:00 PM - 1:05 PM

Agenda Item Image
Professor Coral Gartner
Director, Centre Of Research Excellence On Achieving The Tobacco Endgame
The University Of Queensland

Systematic review and meta-analyses of cytisine to support tobacco cessation

1:05 PM - 1:35 PM

Professor Coral Gartner is an international expert in tobacco control policy and is the Director of the NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame (Tobacco Endgame CRE), an Australian Research Council Future Fellow, and the Chair of the Interdisciplinary Tobacco Endgame Research Network funded by an NHMRC Synergy Grant. She the chair of the Editorial Advisory Board for the BMJ journal, Tobacco Control, after serving as a senior editor from 2012-2018 and then the Australasian regional editor. She is a Past President of the Oceania Chapter of the Society for Research on Nicotine and Tobacco (SRNT-O).
Dr Daniel Stjepanović
Senior Research Fellow
The University Of Queensland

Systematic review and meta-analyses of cytisine to support tobacco cessation

1:05 PM - 1:35 PM

Daniel Stjepanovic is a Senior Research Fellow at the National Centre for Youth Substance Use Research at The University of Queensland. His work focusses on alcohol, cannabis and nicotine use, applying a range of methodologies from experimental designs, large surveys and qualitative interviewing.
Ryan Courtney
A/prof
Unsw

Effect of cytisine versus varenicline on smoking cessation: a randomised controlled trial

1:35 PM - 2:05 PM

Dennis Petrie
Monash University

Cost-effectiveness of cytisine compared to varenicline for smoking cessation: results from a randomised controlled trial

2:05 PM - 2:35 PM

Mr George Krassas
Director
Scius Healthcare Solutions

Cyventine – the introduction of cytisine in Australia: clinical guidance

2:35 PM - 3:05 PM

Dr Melissa Jackson
Research Coordinator / Psychologist
Hunter New England Local Health District, Drug and Alcohol Clinical Services

Can we effectively treat tobacco dependence without addressing cannabis use in people receiving opioid dependence treatment?

3:05 PM - 3:35 PM

Melissa works as a Research Coordinator and Psychologist specialising in substance use and comorbidity. She holds a PhD in Behavioural Science and Master of Clinical Psychology. Her research focuses on tobacco and substance use interventions, both behavioural and pharmacological, and has extensive experience in clinical trials, teaching, and multidisciplinary collaboration.
Ryan Courtney
A/prof
Unsw

PANEL DISCUSSION: Leveraging cytisine for improved smoking cessation and tackling poly tobacco and cannabis use – future steps and directions

3:35 PM - 4:00 PM

Agenda Item Image
Professor Coral Gartner
Director, Centre Of Research Excellence On Achieving The Tobacco Endgame
The University Of Queensland

Panel Member

3:35 PM - 4:00 PM

Dr Melissa Jackson
Research Coordinator / Psychologist
Hunter New England Local Health District, Drug and Alcohol Clinical Services

Panel Member

3:35 PM - 4:00 PM

Mr George Krassas
Director
Scius Healthcare Solutions

Panel Member

3:35 PM - 4:00 PM

Dennis Petrie
Monash University

Panel Member

3:35 PM - 4:00 PM

Dr Daniel Stjepanović
Senior Research Fellow
The University Of Queensland

Panel Member

3:35 PM - 4:00 PM

loading